Prot #A4091059: A Phase 3, Randomized, Double Blind, Placebo and Active-Controlled, Multicenter, Parallel-Group Study of the Analgesic Efficacy and Safety of Tanezumab in Adult Subjects with Chronic Low Back Pain

Project: Research project

StatusFinished
Effective start/end date9/30/159/30/18

Funding

  • inVentiv Health Clinical (Prot #A4091059)
  • Pfizer Inc. (Prot #A4091059)